MCR Live

2018/11/28

Rattler Publishing: The 2018 Rattler Publishing, Gemini, and Shunya Su...

Rattler Publishing: The 2018 Rattler Publishing, Gemini, and Shunya Su...: Midway through the Rattler Publishing, Gemini, Shunya Summit here in Montreal Canada The CEO of Rattler Publishing takes a rest before takin...

1 comment:

  1. How is this drug being sold in Trinidad & Tobago even though it was not approved by the FDA with such dangerous side effects? We need answers!
    Arcoxia
    Generic Name: etoricoxib
    Note: Arcoxia has not been approved by the FDA for the U.S. market. The manufacturer of Arcoxia received a non-approvalable letter from the FDA in April of 2007. This non-approvable letter was due to safety concerns of an increased risk of cardiovascular events (including heart attack and stroke) and questions on the benefit-risk ratio in patients taking Arcoxia. Merck will continue to market Arcoxia outside the United States.

    ReplyDelete

GREAT NEWS/ A BREAK THROUGH

This morning in the Rattler Publishing Meeting, cheers erupted when Tammi Herenichi President of The Gemini Corporation announced there has ...